Literature DB >> 2893295

Inhibition of vasoconstriction to cirazoline by calcium-entry blockade after phenoxybenzamine in rat perfused hindquarters.

C Korstanje1, P A van Zwieten.   

Abstract

The effects of phenoxybenzamine and benextramine were assessed with respect to the vasoconstriction to cirazoline in rat perfused hindquarters. Experiments were performed with and without restriction of inward calcium flux by addition of nifedipine (10(-9)-10(-6) M) to the standard physiological solution (PS), or by omission of calcium chloride from the PS. Addition of nifedipine or omission of Ca2+ did not affect the maximal response or potency of the selective but partial alpha 1-adrenoceptor agonist, cirazoline in rat perfused hindquarters. Upon pretreatment with phenoxybenzamine (0.03-30 micrograms/kg, i.v. at -1 h) or benextramine (1 mg/kg, i.v. at -2 h) both the slope and the maximal response to cirazoline were depressed. After phenoxybenzamine but not after benextramine the maximal response to cirazoline was depressed further upon addition of nifedipine or omission of Ca2+ from the PS. It is concluded that phenoxybenzamine selectively inhibits that part of the alpha 1-adrenoceptor mediated vasoconstriction that is independent of extracellular calcium, thereby unmasking a calcium-entry sensitive mechanism of vasoconstriction to cirazoline.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893295     DOI: 10.1007/bf00164874

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  Alpha 1- and alpha 2-adrenoceptor-mediated pressor responses: are they differentiated by calcium antagonists or by functional antagonism?

Authors:  M J Lew; J A Angus
Journal:  J Cardiovasc Pharmacol       Date:  1985 Mar-Apr       Impact factor: 3.105

2.  Ca2+ sources mobilized by alpha 1-receptor activation in vascular smooth muscle.

Authors:  P Leijten; C Cauvin; N Lodge; K Saida; C Van Breemen
Journal:  Clin Sci (Lond)       Date:  1985       Impact factor: 6.124

3.  Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.

Authors:  L Cubeddu; E M Barnes; S Z Langer; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1974-09       Impact factor: 4.030

4.  The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors.

Authors:  T P Kenakin
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

5.  Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes.

Authors:  C Korstanje; B Wilffert; A de Jonge; M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

6.  Differential effects of the calcium entry blocker D 600 on contractions of rat and guinea-pig aortas, elicited by various alpha-1 adrenoceptor agonists.

Authors:  J J Beckeringh; M J Thoolen; A de Jonge; B Wilffert; P B Timmermans; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1984-05       Impact factor: 4.030

7.  Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

Authors:  I Cavero; N Shepperson; F Lefèvre-Borg; S Z Langer
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

8.  Recovery of alpha-adrenoreceptor mediated responses and binding site number after intravenous benextramine in the rabbit.

Authors:  G Furnace; C A Hamilton; J L Reid; D J Sumner
Journal:  J Auton Pharmacol       Date:  1985-03

9.  Effects of the irreversible alpha-adrenoceptor antagonists phenoxybenzamine and benextramine on the effectiveness of nifedipine in inhibiting alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in pithed rats.

Authors:  P B Timmermans; M J Thoolen; M J Mathy; B Wilffert; A de Jonge; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

10.  Phenoxybenzamine is more potent in inactivating alpha 1- than alpha 2-adrenergic receptor binding sites.

Authors:  K P Minneman
Journal:  Eur J Pharmacol       Date:  1983-10-14       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.